Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Genmab (United States)

InstitutionResearch output, impact & collaborations

Genmab (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Genmab (United States)?

ScholarIQrecord summary

Genmab (United States) is a research organisation in Princeton, US. OpenAlex records 753 works and 43,308 citations for it. 333 researchers list it as their most recent affiliation.

How many works does Genmab (United States) have?

ScholarIQindexed works

Genmab (United States) has 753 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Genmab (United States) have?

ScholarIQcitation count

Genmab (United States) has 43,308 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Genmab (United States)?

ScholarIQresearcher count

Genmab (United States) has 333 researchers in the ScholarIQ index.

What is the average h-index at Genmab (United States)?

ScholarIQavg h-index

Genmab (United States) has an average h-index of 49 in OpenAlex.

What is the ROR of Genmab (United States)?

ScholarIQror

The ROR for Genmab (United States) is on the source record.

What is the OpenAlex record for Genmab (United States)?

ScholarIQopenalex

The OpenAlex for Genmab (United States) is on the source record.

What is the Wikidata of Genmab (United States)?

ScholarIQwikidata

The Wikidata for Genmab (United States) is on the source record.

Who are the most-cited researchers behind Genmab (United States)?

ScholarIQtop researchers by citations
1
Jan G. J. van de Winkel · Monoclonal and Polyclonal Antibodies Research
316 works22,332 citations
2
Neeraj N. Iyer · Hemophilia Treatment and Research
53 works679 citations

What are the most-cited papers on Genmab (United States)?

ScholarIQmost cited works
Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice
Wouter L. W. Hazenbos, J. Engelbert Gessner, Frans M.A. Hofhuis, Henri Kuipers, Dirk Meyer, Ingmar Heijnen, Reinhold Schmidt, Mátyás Sándor, P J Capel, Marc Daëron, Jan G. J. van de Winkel, J. Sjef Verbeek
Immunity. 1996448 CitationsOPEN ACCESS
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Michael Wang, Katharine Batt, Craig M. Kessler, Anne T. Neff, Neeraj N. Iyer, David L. Cooper, Christine L. Kempton
Patient Preference and Adherence. 201754 CitationsOPEN ACCESS
Impact of hemophilia B on quality of life in affected men, women, and caregivers—Assessment of patient‐reported outcomes in the B‐<scp>HERO</scp>‐S study
Tyler W. Buckner, Michelle Witkop, Christine Guelcher, Robert F. Sidonio, Craig M. Kessler, David B. Clark, Wendy Owens, Neil Frick, Neeraj N. Iyer, David L. Cooper
European Journal Of Haematology. 201844 CitationsOPEN ACCESS
One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy
David Portman, L.P. Shulman, Jason Yeaw, Sha Zeng, Chioma Uzoigwe, Ricardo Maamari, Neeraj N. Iyer
Menopause The Journal of The North American Menopause Society. 201536 Citations

How much of the research on Genmab (United States) is open access?

ScholarIQopen access share
92%OPEN ACCESS
Gold
42%
Green
0%
Hybrid
25%
Bronze
25%
Closed
8%

Related on ScholarIQ

Lymphoma Diagnosis and Treatment
Top Topic
CAR-T cell therapy research
Top Topic
Monoclonal and Polyclonal Antibodies Research
Top Topic
Chronic Lymphocytic Leukemia Research
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
HER2/EGFR in Cancer Research
Top Topic
470M+ articles · 14-day free trial